Currently, there are 124.85M common shares owned by the public and among those 76.86M shares have been available to trade.
The company’s stock has a 5-day price change of 30.89% and 332.53% over the past three months. VOR shares are trading 174.66% year to date (YTD), with the 12-month market performance up to 125.23% higher. It has a 12-month low price of $0.13 and touched a high of $3.29 over the same period. VOR has an average intraday trading volume of 17.11 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 115.39%, 296.41%, and 187.09% respectively.
Institutional ownership of Vor Biopharma Inc (NASDAQ: VOR) shares accounts for 42.14% of the company’s 124.85M shares outstanding.
It has a market capitalization of $312.40M and a beta (3y monthly) value of 2.05. The earnings-per-share (ttm) stands at -$1.51. Price movements for the stock have been influenced by the stock’s volatility, which stands at 33.21% over the week and 37.68% over the month.
Earnings per share for the fiscal year are expected to increase by 56.45%, and 36.23% over the next financial year. EPS should grow at an annualized rate of 18.66% over the next five years, compared to -38.02% over the past 5-year period.
Looking at the support for the VOR, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on June 30, 2025, with the firm’s price target at $3. Wedbush coverage for the Vor Biopharma Inc (VOR) stock in a research note released on July 26, 2022 offered a Outperform rating with a price target of $18. Goldman was of a view on April 27, 2022 that the stock is Neutral, while H.C. Wainwright gave the stock Buy rating on December 17, 2021, issuing a price target of $26. Robert W. Baird on their part issued Outperform rating on December 03, 2021.
